North America Needle Free Injections Market Outlook to 2023

Published : Aug-2017

No. of Pages : 95

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Needle Free Injections Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 7
3 Needle Free Injections Market, North America 8
3.1 Needle Free Injections Market, North America, Revenue ($m), 2009-2023 8
3.2 Needle Free Injections Market, North America, Revenue ($m), 2009-2016 10
3.3 Needle Free Injections Market, North America, Revenue ($m), 2016-2023 11
3.4 Needle Free Injections Market, North America, Volume (Units), 2009-2023 12
3.5 Needle Free Injections Market, North America, Volume (Units), 2009-2016 13
3.6 Needle Free Injections Market, North America, Volume (Units), 2016-2023 14
3.7 Needle Free Injections Market, North America, Company Share by Revenue ($m), 2016 15
4 Needle Free Injections Market, Canada 17
4.1 Needle Free Injections Market, Canada, Revenue ($m), 2009-2016 17
4.2 Needle Free Injections Market, Canada, Revenue ($m), 2016-2023 18
4.3 Needle Free Injections Market, Canada, Volume (Units), 2009-2016 19
4.4 Needle Free Injections Market, Canada, Volume (Units), 2016-2023 20
4.5 Needle Free Injections Market, Canada, Average Price ($), 2009-2023 21
4.6 Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), 2015-2016 22
4.7 Needle Free Injections Market, Canada, Company Share by Revenue ($m), 2016 23
5 Needle Free Injections Market, Mexico 25
5.1 Needle Free Injections Market, Mexico, Revenue ($m), 2009-2016 25
5.2 Needle Free Injections Market, Mexico, Revenue ($m), 2016-2023 26
5.3 Needle Free Injections Market, Mexico, Volume (Units), 2009-2016 27
5.4 Needle Free Injections Market, Mexico, Volume (Units), 2016-2023 28
5.5 Needle Free Injections Market, Mexico, Average Price ($), 2009-2023 29
5.6 Needle Free Injections Market, Mexico, Distribution Share by Revenue ($m), 2015-2016 30
5.7 Needle Free Injections Market, Mexico, Company Share by Revenue ($m), 2016 31
6 Needle Free Injections Market, United States 33
6.1 Needle Free Injections Market, United States, Revenue ($m), 2009-2016 33
6.2 Needle Free Injections Market, United States, Revenue ($m), 2016-2023 34
6.3 Needle Free Injections Market, United States, Volume (Units), 2009-2016 35
6.4 Needle Free Injections Market, United States, Volume (Units), 2016-2023 36
6.5 Needle Free Injections Market, United States, Average Price ($), 2009-2023 37
6.6 Needle Free Injections Market, United States, Distribution Share by Revenue ($m), 2015-2016 38
6.7 Needle Free Injections Market, United States, Company Share by Revenue ($m), 2016 39
7 Overview of Key Companies in North America Needle Free Injections Market 41
7.1 INJEX - Equidyne Systems 41
7.1.1 Company Overview 41
7.2 Bioject Medical Technologies Inc 41
7.2.1 Company Overview 41
7.3 Antares Pharma Inc 41
7.3.1 Company Overview 41
7.4 PharmaJet Inc 41
7.4.1 Company Overview 41
7.5 MK Global Co. 42
7.5.1 Company Overview 42
8 Needle Free Injections Market Pipeline Products 43
9 Recent Developments 44
9.1 Corporate Communications 44
9.1.1 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 44
9.1.2 Jun 06, 2017: Valeritas Appoints Peter J. Devlin to Chairman of its Board of Directors 44
9.1.3 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 44
9.1.4 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 45
9.1.5 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 45
9.1.6 Jan 05, 2017: Zogenix Announces CFO Transition 45
9.1.7 Nov 30, 2016: Valeritas Elects Joe Mandato, Ph.D., Experienced Medical Device Executive and Investor, to Board of Directors 46
9.1.8 Nov 17, 2016: OSE Immunotherapeutics announces the online publication of positive Phase 1 clinical results with FR104 in the Journal of Immunology 47
9.1.9 Nov 15, 2016: Oncoceutics Presents Abstracts on ONC201 at 2016 American Society of Hematology Meeting 48
9.1.10 Nov 14, 2016: Olympus VISERA 4K UHD Receives "Excellence in Surgical Products Awards," Minimally Invasive Surgical Product Category 49
9.1.11 Oct 31, 2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer 50
9.1.12 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 50
9.1.13 Sep 22, 2016: Industry Veteran Katherine D. Crothall, PhD to Join Valeritas Board of Directors 51
9.1.14 Aug 16, 2016: Valeritas Appoints Erick J. Lucera as Chief Financial Officer 51
9.2 Financial Announcements 52
9.2.1 May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results 52
9.2.2 May 12, 2017: Valeritas Reports First Quarter 2017 Financial Results 52
9.2.3 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 53
9.2.4 May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results 54
9.2.5 May 04, 2017: Zogenix Reports First Quarter 2017 Financial Results 55
9.2.6 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 55
9.2.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 57
9.2.8 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 58
9.2.9 Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results 59
9.2.10 Mar 14, 2017: Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results 60
9.2.11 Mar 09, 2017: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results 61
9.2.12 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 63
9.2.13 Feb 21, 2017: Valeritas Reports Fourth Quarter and Full Year 2016 Financial Results 63
9.2.14 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 64
9.2.15 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 65
9.2.16 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 67
9.2.17 Nov 10, 2016: Valeritas Reports Third Quarter 2016 Financial Results 69
9.2.18 Nov 09, 2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results 69
9.2.19 Nov 09, 2016: Aradigm Announces Third Quarter 2016 Financial Results 71
9.2.20 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 72
9.2.21 Nov 08, 2016: Zogenix Provides Corporate Update and Reports Third Quarter 2016 Financial Results 72
9.2.22 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 73
9.2.23 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 75
9.2.24 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 76
9.2.25 Aug 10, 2016: Aradigm Announces Second Quarter 2016 Financial Results 78
9.2.26 Aug 10, 2016: Valeritas Reports Second Quarter 2016 Financial Results 79
9.2.27 Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results 80
9.2.28 Aug 09, 2016: Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results 81
9.2.29 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 82
9.2.30 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 83
9.2.31 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 84
9.3 Government and Public Interest 85
9.3.1 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 85
9.3.2 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 86
9.4 Legal And Regulatory 86
9.4.1 Dec 22, 2016: Teva Pharmaceutical Paying $519 Million to Settle FCPA Charges 86
9.4.2 Nov 17, 2016: New Data from Global aHUS Registry Presented at ASN 2016 Show a Three-Fold Reduction in Post-Transplant Dialysis in Patients Initiating Soliris (eculizumab) Treatment Prior to Transplant Compared to Initiating Treatment Post-Transplant 87
9.5 Other Significant Developments 88
9.5.1 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 88
9.5.2 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 90
10 Appendix 91
10.1 Research Methodology 92
10.1.1 Coverage 92
10.1.2 Secondary Research 92
10.1.3 Primary Research 93
10.1.4 Company Share Analysis 93
10.1.5 Distribution Share Analysis 93
10.1.6 Benchmarking 94
10.2 GlobalData Consulting 94
10.3 Contact Us 95
10.4 Disclaimer 95

1.1 List of Tables
Table 1: Needle Free Injections Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 9
Table 2: Needle Free Injections Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 10
Table 3: Needle Free Injections Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 11
Table 4: Needle Free Injections Market, North America, Volume (Units), 2009-2023 12
Table 5: Needle Free Injections Market, North America, Volume (Units), Historic, 2009-2016 13
Table 6: Needle Free Injections Market, North America, Volume (Units), Forecast, 2016-2023 14
Table 7: Needle Free Injections Market, North America, Company Share by Revenue ($m), USD Constant, 2016 16
Table 8: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 9: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Table 10: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016 19
Table 11: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023 20
Table 12: Needle Free Injections Market, Canada, Average Price ($), Historic, 2009-2016 21
Table 13: Needle Free Injections Market, Canada, Average Price ($), Forecast, 2016-2023 21
Table 14: Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 22
Table 15: Needle Free Injections Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 24
Table 16: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 25
Table 17: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 26
Table 18: Needle Free Injections Market, Mexico, Volume (Units), Historic, 2009-2016 27
Table 19: Needle Free Injections Market, Mexico, Volume (Units), Forecast, 2016-2023 28
Table 20: Needle Free Injections Market, Mexico, Average Price ($), Historic, 2009-2016 29
Table 21: Needle Free Injections Market, Mexico, Average Price ($), Forecast, 2016-2023 29
Table 22: Needle Free Injections Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2015-2016 30
Table 23: Needle Free Injections Market, Mexico, Company Share by Revenue ($m), USD Constant, 2016 32
Table 24: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 33
Table 25: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 34
Table 26: Needle Free Injections Market, United States, Volume (Units), Historic, 2009-2016 35
Table 27: Needle Free Injections Market, United States, Volume (Units), Forecast, 2016-2023 36
Table 28: Needle Free Injections Market, United States, Average Price ($), Historic, 2009-2016 37
Table 29: Needle Free Injections Market, United States, Average Price ($), Forecast, 2016-2023 37
Table 30: Needle Free Injections Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
Table 31: Needle Free Injections Market, United States, Company Share by Revenue ($m), USD Constant, 2016 40
Table 32: Needle Free Injections Market Pipeline Products 43

1.2 List of Figures
Figure 1: Needle Free Injections Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023 8
Figure 2: Needle Free Injections Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016 10
Figure 3: Needle Free Injections Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023 11
Figure 4: Needle Free Injections Market, North America, Volume (Units), 2009-2023 12
Figure 5: Needle Free Injections Market, North America, Volume (Units), Historic, 2009-2016 13
Figure 6: Needle Free Injections Market, North America, Volume (Units), Forecast, 2016-2023 14
Figure 7: Needle Free Injections Market, North America, Company Share (%) 2016 15
Figure 8: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 17
Figure 9: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Figure 10: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016 19
Figure 11: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023 20
Figure 12: Needle Free Injections Market, Canada, Company Share (%) 2016 23
Figure 13: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016 25
Figure 14: Needle Free Injections Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023 26
Figure 15: Needle Free Injections Market, Mexico, Volume (Units), Historic, 2009-2016 27
Figure 16: Needle Free Injections Market, Mexico, Volume (Units), Forecast, 2016-2023 28
Figure 17: Needle Free Injections Market, Mexico, Company Share (%) 2016 31
Figure 18: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 33
Figure 19: Needle Free Injections Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 34
Figure 20: Needle Free Injections Market, United States, Volume (Units), Historic, 2009-2016 35
Figure 21: Needle Free Injections Market, United States, Volume (Units), Forecast, 2016-2023 36
Figure 22: Needle Free Injections Market, United States, Company Share (%) 2016 39

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

North America Needle Free Injections Market Outlook to 2023

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027